Literature DB >> 698739

Does labetalol increase excretion of urinary catecholamines?

C A Hamilton, D H Jones, H J Dargie, J L Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 698739      PMCID： PMC1607867          DOI： 10.1136/bmj.2.6140.800

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Improved technique for the fluorimetric estimation of catecholamines.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1961-04

2.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Labetalol and urinary catecholamines.

Authors:  B P Chapman; A G Veitch; B Shepherd
Journal:  Br Med J       Date:  1978-02-11
  3 in total
  9 in total

Review 1.  Neurogenic aspects of essential hypertension in man.

Authors:  G A FitzGerald
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

2.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.

Authors:  H J Kornerup; E B Pedersen; N J Christensen; A Pedersen; G Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

4.  Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.

Authors:  T Rosenthal; B Rabinowitz; H Boichis; E Elazar; A Brauner; H N Neufeld
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.

Authors:  P M Bouloux; R M Featherstone; V Clement-Jones; L H Rees; J E Goligher
Journal:  J R Soc Med       Date:  1985-07       Impact factor: 5.344

6.  A long-term study of labetalol in general practice.

Authors:  J Kane; I Gregg; M D Stephens
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.

Authors:  G Keusch; P Weidmann; W H Ziegler; R de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-01-02

Review 8.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

9.  Ventricular myosin pattern of spontaneously hypertensive turkeys is unaffected by labetalol treatment.

Authors:  P Pauletto; G Vescovo; G Scannapieco; A Angelini; L Dalla Libera; U Carraro; F Tessari; C Dal Palù
Journal:  Basic Res Cardiol       Date:  1988 May-Jun       Impact factor: 17.165
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.